The association between warfarin usage and international normalized ratio increase: systematic analysis of FDA Adverse Event Reporting System (FAERS)

Abstract

Introduction: Elevated international normalized ratio (INR) has been commonly reported as an adverse drug event (ADE) for patients taking warfarin for anticoagulant therapy.

Aim: The purpose of this study was to determine the association between increased INR and the usage of warfarin by using the pharmacovigilance data from the FDA Adverse Event Reporting System (FAERS).

Methods: The ADEs in patients who took warfarin (N = 77,010) were analyzed using FAERS data. Association rule mining was applied to identify warfarin-related ADEs that were most associated with elevated INR (n = 15,091) as well as possible drug-drug interactions (DDIs) associated with increased INR. Lift values were used to identify ADEs that were most commonly reported alongside elevated INR based on the correlation between both item sets. In addition, this study sought to determine if the increased INR risk was influenced by sex, age, temporal distribution, and geographic distribution and were reported as reporting odds ratios (RORs).

Results: The top 5 ADEs most associated with increased INR in patients taking warfarin were decreased hemoglobin (lift = 2.31), drug interactions (lift = 1.88), hematuria (lift = 1.58), asthenia (lift = 1.44), and fall (lift = 1.32). INR risk increased as age increased, with individuals older than 80 having a 63% greater likelihood of elevated INR compared to those younger than 50. Males were 9% more likely to report increased INR as an ADE compared to females. Individuals taking warfarin concomitantly with at least one other drug were 43% more likely to report increased INR. The top 5 most frequently identified DDIs in patients taking warfarin and presenting with elevated INR were acetaminophen (lift = 1.81), ramipril (lift = 1.71), furosemide (lift = 1.64), bisoprolol (lift = 1.58), and simvastatin (lift = 1.58).

Conclusion: The risk of elevated INR increased as patient age increased, particularly among those older than 80. Elevated INR frequently co-presented with decreased hemoglobin, drug interactions, hematuria, asthenia, and fall in patients taking warfarin. This effect may be less pronounced in women due to the procoagulatory effects of estrogen signaling. Multiple possible DDIs were identified, including acetaminophen, ramipril, and furosemide.

Keywords

Warfarin / FAERS / FDA / pharmacovigilance / international normalized ratio / INR

References

[1] Jacobs LG.Warfarin pharmacology, clinical management, and evaluation of hemorrhagic risk for the elderly.Cardiol Clin2008;26:157-67

[2] Patel S,Preuss CV. Warfarin. In: Treasure island. FL: StatPearls; 2023.

[3] Ashorobi D,Fernandez R. Thrombosis. In: Treasure island. FL: StatPearls; 2023.

[4] Ansell J,Hylek E,Crowther M.Pharmacology and management of the vitamin K antagonists: American college of chest physicians evidence-based clinical practice guidelines (8th Edition).Chest2008;133:160S-98S

[5] Rishavy MA,Wilson L,Runge KW.Warfarin alters vitamin K metabolism: a surprising mechanism of VKORC1 uncoupling necessitates an additional reductase.Blood2018;131:2826-35 PMCID:PMC6014353

[6] Harutyunyan HA.Prothrombin and fibrinogen carbonylation: how that can affect the blood clotting.Redox Rep2017;22:160-5 PMCID:PMC6837719

[7] Zermatten MG,Calderara DB,Moradpour D.Biomarkers of liver dysfunction correlate with a prothrombotic and not with a prohaemorrhagic profile in patients with cirrhosis.JHEP Rep2020;2:100120 PMCID:PMC7369360

[8] Dorgalaleh A,Bahraini M.Standardization of prothrombin time/international normalized ratio (PT/INR).Int J Lab Hematol2021;43:21-8

[9] Shikdar S,Bhattacharya PT. International normalized ratio (INR). In: Treasure island. FL: StatPearls; 2023.

[10] Al-Momany NH,Al-Omari NA,Momani RO.Analysis of factors that interrupt with INR control in the first anticoagulation clinic monitoring jordanian patients.Clin Appl Thromb Hemost2019;25:1076029619870252 PMCID:PMC6829640

[11] Elango K,Khetarpal BK.The effects of warfarin and direct oral anticoagulants on systemic vascular calcification: a review.Cells2021;10:773 PMCID:PMC8066517

[12] Morris R,Jose RP.Bradycardia due to donepezil in adults: systematic analysis of FDA adverse event reporting system.J Alzheimers Dis2021;81:297-307

[13] Morris R,Bu K.The association between use of rivastigmine and pneumonia: systematic analysis of FDA adverse event reporting system.J Alzheimers Dis2021;83:1061-71

[14] Bu K,Morris R.Dysphagia risk in patients prescribed rivastigmine: a systematic analysis of FDA adverse event reporting system.J Alzheimers Dis2022;89:721-31

[15] Han L,Pamer CA,Proestel S.Development of an automated assessment tool for MedWatch reports in the FDA adverse event reporting system.J Am Med Inform Assoc2017;24:913-20 PMCID:PMC7651970

[16] Kodani E,Atarashi H,Yamashita T.Impact of hemoglobin concentration and platelet count on outcomes of patients with non-valvular atrial fibrillation: a subanalysis of the J-RHYTHM registry.Int J Cardiol2020;302:81-7

[17] Lim AK.Haematuria and acute kidney injury in elderly patients admitted to hospital with supratherapeutic warfarin anticoagulation.Int Urol Nephrol2013;45:561-70

[18] Donley ER,Loyd JW. Hemorrhage control. In: Treasure island. FL: StatPearls; 2023.

[19] Favaloro EJ,Lippi G.Aging hemostasis: changes to laboratory markers of hemostasis as we age - a narrative review.Semin Thromb Hemost2014;40:621-33

[20] Mari D,Castaldi D,Bollini EM.Hemostasis and ageing.Immun Ageing2008;5:12 PMCID:PMC2602988

[21] Amin H,Aslam M.Coagulation factors and antithrombin levels in young and elderly subjects in Pakistani population.Blood Coagul Fibrinolysis2012;23:745-50

[22] Ribak G,Froom P.Older age is risk for an international normalized ratio (INR) of 5 or more.Clin Lab2007;53:571-4

[23] Abou-Ismail MY,Nayak L.Estrogen and thrombosis: a bench to bedside review.Thromb Res2020;192:40-51 PMCID:PMC7341440

[24] Tsuchida T,Nakae R.Gender-related differences in the coagulofibrinolytic responses and long-term outcomes in patients with isolated traumatic brain injury: a 2-center retrospective study.Medicine2023;102:e32850 PMCID:PMC9907995

[25] Dean L. Warfarin therapy and VKORC1 and CYP genotype. In: Medical genetics summaries. MD: Bethesda; 2012.

[26] Fung E,Belknap SM.Effect of genetic variants, especially CYP2C9 and VKORC1, on the pharmacology of warfarin.Semin Thromb Hemost2012;38:893-904 PMCID:PMC4134937

[27] Sikorska J.Direct oral anticoagulants: a quick guide.Eur Cardiol2017;12:40-5 PMCID:PMC6206466

[28] Dayoub EJ,Shah ND.Evolution of medicare formulary coverage changes for antithrombotic therapies after guideline updates.Circulation2019;140:1227-30

[29] Wheelock KM,Murugiah K,Krumholz HM.Clinician trends in prescribing direct oral anticoagulants for US medicare beneficiaries.JAMA Netw Open2021;4:e2137288 PMCID:PMC8649845

[30] Makam RCP,McManus DD.Efficacy and safety of direct oral anticoagulants approved for cardiovascular indications: systematic review and meta-analysis.PLoS One2018;13:e0197583 PMCID:PMC5967718

[31] Lu Y,Pietsch M.A novel algorithm for analyzing drug-drug interactions from MEDLINE literature.Sci Rep2015;5:17357 PMCID:PMC4661569

[32] Lu Y,Huang H,Wang J.Characterization of the mechanism of drug-drug interactions from PubMed using MeSH terms.PLoS One2017;12:e0173548 PMCID:PMC5396881

[33] Lu Y,Pham M,Cheng F.CuDDI: a CUDA-based application for extracting drug-drug interaction related substance terms from PubMed literature.Molecules2019;24:1081 PMCID:PMC6470591

[34] Lopes RD,Garcia DA,Hylek EM.Warfarin and acetaminophen interaction: a summary of the evidence and biologic plausibility.Blood2011;118:6269-73 PMCID:PMC5524527

[35] Whyte IM,Reith DM,Seldon M.Acetaminophen causes an increased International Normalized Ratio by reducing functional factor VII.Ther Drug Monit2000;22:742-8

[36] Leong D.Warfarin and acetaminophen interaction in a 47-year-old woman.CMAJ2020;192:E506-8 PMCID:PMC7234266

[37] Herman LL,Ahmed I. Angiotensin converting enzyme inhibitors (ACEI). In: Treasure island. FL: StatPearls; 2023.

[38] Gibbs CR,Watson RD.Abnormalities of hemorheological, endothelial, and platelet function in patients with chronic heart failure in sinus rhythm: effects of angiotensin-converting enzyme inhibitor and beta-blocker therapy.Circulation2001;103:1746-51

[39] Pahor M,Deitcher SR.Fosinopril versus amlodipine comparative treatments study: a randomized trial to assess effects on plasminogen activator inhibitor-1.Circulation2002;105:457-61

[40] Phillips W,Williamson JD.Risk of hospitalized gastrointestinal bleeding in persons randomized to diuretic, ACE-inhibitor, or calcium-channel blocker in ALLHAT.J Clin Hypertens2013;15:825-32 PMCID:PMC3844932

[41] Huxel C,Ollivierre-Lawrence MD. Loop diuretics. In: Treasure island. FL: StatPearls; 2023.

[42] Farzam K. Beta blockers. In: Treasure island. FL: StatPearls; 2023.

[43] Berlowitz DR,Oliveria SA,Gomez-Caminero A.Differential associations of beta-blockers with hemorrhagic events for chronic heart failure patients on warfarin.Pharmacoepidemiol Drug Saf2006;15:799-807

[44] Ma Y,Yang J.Association between pre-existing long-term β-blocker therapy and the outcomes of sepsis-associated coagulopathy: a retrospective study.Medicina2022;58:1843 PMCID:PMC9786011

[45] Mantero F,Vicariotto MA.Effect of atenolol and metoprolol on the anticoagulant activity of acenocoumarin.Br J Clin Pharmacol1984;17 Suppl 1:94S-6S PMCID:PMC1463252

[46] Preckel D.Regulation of hemostasis by the sympathetic nervous system: any contribution to coronary artery disease?.Heartdrug2004;4:123-30 PMCID:PMC2629605

[47] Andersson ML,Lindh JD.The effect of simvastatin on warfarin anticoagulation: a Swedish register-based nationwide cohort study.Eur J Clin Pharmacol2019;75:1387-92

[48] Shaik AN,Williams DA,LeDuc BW.Mechanism of drug-drug interactions between warfarin and statins.J Pharm Sci2016;105:1976-86